Skip to main content

oral P2Y12 inhibitors

Original Contribution
12/01/2021
Bryce Johnson, MD and colleagues aimed to characterize outcomes associated with cangrelor administration used in an antiplatelet bridging strategy in real-world clinical scenarios within a large academic medical system.
Bryce Johnson, MD and colleagues aimed to characterize outcomes associated with cangrelor administration used in an antiplatelet bridging strategy in real-world clinical scenarios within a large academic medical system.
Bryce Johnson, MD and colleagues...
12/01/2021
Journal of Invasive Cardiology